Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) is a development-stage company focused on an AI-based orthodontic alignment platform called ZSmile. The ZSmile Platform, a Class II medical device, received 510(k) clearance from the FDA for commercialization in the U.S. in February 2026, building on its first-generation Aerodentis System which received FDA clearance in April 2020. The company is not currently generating revenues and incurred net losses of $2.5 million in 2025 and $5.8 million in 2024. As of December 31, 2025, the company had cash of approximately $228,000, a working capital deficit of $2.7 million, and an accumulated deficit of $22 million. The independent registered public accounting firm expressed substantial doubt about the company's ability to continue as a going concern due to recurring losses and insufficient liquidity. Dror Ortho-Design plans to spend approximately $1 million over the next 12 months on software and hardware development, regulatory approvals, and IP protection. The company raised $1.75 million in bridge loans from existing investors during 2025 and an additional $200,000 in February 2026, with these debentures convertible into common stock upon a public offering. The ZSmile Platform utilizes a smartphone application, an AI-based cloud service, and a smart aligner system that uses pulsating air for nighttime tooth movement, requiring only one aligner per patient. The global clear aligners market was estimated at $8.3 billion in 2025 and is projected to reach $56.8 billion by 2033, with Dror Ortho-Design targeting a potential addressable market of $17 billion. The company's business model aims to expand the target distribution channel to general dentists, who outnumber orthodontists by approximately 15 to 1 in the U.S. The company has three issued U.S. patents (expiring 2030, 2040, 2040) and four pending U.S. patents covering its technology. A material weakness in internal control over financial reporting was identified as of December 31, 2025, due to limited accounting personnel and the absence of a Chief Financial Officer. The company's operations are based in Israel, exposing it to economic, political, geopolitical, and military risks, including recent conflicts with Hamas, Hezbollah, and Iran.